All

1003 Expert Conversations

    1003 Expert Conversations
    Esophageal cancer treatment FAQ. Prognosis. When surgery is not beneficial? 11
    Future in esophageal cancer treatment. Precision medicine. Tumor genome sequencing. 10
    Lung cancer treatment. Minimally invasive surgery. VATS. Robotic surgery for lung cancer. 9
    Esophageal carcinoma. Minimally invasive surgery vs. classic surgery. Surgeon’s skill is paramount. 8
    Esophageal carcinoma radiotherapy. ‘East’ vs. ‘West’ differences in radiotherapy use. 7
    Esophageal carcinoma. Neoadjuvant chemotherapy vs. upfront surgery. 6
    Esophageal carcinoma diagnosis. PET CT. Endoscopic ultrasound. Cure at early stage is possible. 5
    Esophageal carcinoma risks and symptoms. ‘East’ vs. ‘West’ differences in esophageal cancer. 4
    GERD anti-reflux surgery often fails after 10 years. PPI medications and esophageal cancer risk. 3
    Does GERD anti-reflux surgery reduce esophageal cancer risks? The risk does not go down to zero. 2
    Dr. Jari Rasanen. Esophageal cancer and Lung cancer expert. Biography. 0
    How to select drug combinations for multiple myeloma treatment? 7
    Multiple myeloma. Message of hope for cancer treatment and for life. 14
    Multiple myeloma. Patient’s story: elderly woman and ‘last hope’ CAR T-cell therapy. 13
    Multiple myeloma. FAQ: Immunization, Vitamin D and bone health, quality of life. 12
    Future in multiple myeloma treatment. When will it be a ‘curable disease’? 11
    Castleman Disease. Subtypes and treatment options. 10
    Multiple myeloma. Minimal Residual Disease evaluation. Prognosis. 9
    Chimeric antigen receptor T-cell therapy in multiple myeloma. CAR T-cell immunotherapy. 8
    Autologous stem cell transplantation in multiple myeloma. 6
    Multiple myeloma. Risk stratification criteria to select the best treatment for each patient. 5
    Multiple myeloma and gene expression profiling. Intraclonal heterogeneity. 4
    Multiple myeloma and bone marrow microenvironment. ‘Seed and soil’ concept in cancer progression. 3
    Multiple myeloma. Genetic changes. MGUS. Smoldering myeloma. 2
    Multiple myeloma. Progress and challenges of treatment. 1
    Dr. Nikhil Munshi. Multiple myeloma expert. Biography. 0
    ‘Mentorship is crucial for successful medical career’. Prof. Scott L. Friedman. 18
    Most patients with fatty liver disease & NASH do not have symptoms. Alcohol is often not to blame. 17
    How to improve health of your liver? Difficulty to keep low weight. 16
    FAQ from patients with fatty liver disease. Life quality, prognosis, alcohol use. 15
    Future of liver disease treatment. Xenotransplantation of liver. 14
    Coffee reduces risks of liver disease. Coffee and NAFLD prevention. 13
    Leading drug candidates for NASH therapy. NAFLD, fatty liver disease treatment. 12
    When new drugs will be approved for fatty liver disease? 11
    Liver cancer risk and fatty liver disease. Cancer screening in NASH, NAFLD. 10
    Hepatic Stellate Cells cause fatty liver disease. NAFLD and NASH causes. 9
    Food supplements and generic drugs for NASH and NAFLD. 8
    Gut microbiome and fatty liver disease. NAFLD, NASH, and Fecal transplantation. 7
    Genetic tests to find risks for liver disease [NAFLD and NASH]. 6
    How NASH differs from NAFLD. What drives progression to NASH? 5
    Recently viewed Expert Conversations